|
|
Volumn 94, Issue 16, 2002, Pages 1194-1195
|
|
Heat shock protein inhibitor shows antitumor activity
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANSAMYCIN DERIVATIVE;
ANTINEOPLASTIC ANTIBIOTIC;
BCR ABL PROTEIN;
BENZOQUINONE;
GELDANAMYCIN;
HEAT SHOCK PROTEIN 90;
IMATINIB;
ONCOPROTEIN;
PACLITAXEL;
PROTEIN INHIBITOR;
PROTEIN P53;
PROTEIN TYROSINE KINASE;
ACHIEVEMENT;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER RESEARCH;
CARCINOGENESIS;
CELL COMMUNICATION;
CLINICAL TRIAL;
CYTOLOGY;
DRUG EFFICACY;
DRUG SAFETY;
GENE MUTATION;
HUMAN;
LEUKEMIA;
LUNG CANCER;
NOTE;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
SIDE EFFECT;
TUMOR CELL;
UNITED KINGDOM;
|
|
EID: 0037151349
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.16.1194 Document Type: Note |
|
Times cited : (16)
|
|
References (0)
|